Apeloa

Sitemap

Home

About

About us

Leadership

Scientific advisory board

Product & Services

Aesthetic & Care Ingredients

Technology Platforms

DS Technology Platforms Flow Chemistry Synthetic Biology & Biocatalysis Crystallization & Particle Engineering Peptide High Potency Compound Conjugate Library Service Oligonucleotide Synthesis Preparation & Purification DP Technology Platforms Controlled-release Formulation Development Taste Masking Technology Particle Flow Simulation Technical Support Centers Analytical Testing Center Process Safety Center

News

Events BIO KOREA 2025 CPHI Japan 2025 in-cosmetics Global 2025 APS Seminar & Party DCAT Week 2025 BioEurope Spring 2025 2025 SAPA-GP Annual Conference 53rd Organic Process Research and Development Conference TIDES Asia 2025 PCHi 2025 15th COSME Week Tokyo 43rd Annual J.P. Morgan Healthcare Conference CPHI Middle East 2024 41st Medicinal Chemistry Symposium BioEurope 2024 15th World ADC Conference CPHI Milan 2024 CBA Annual Conference 2024 SAPA 2024 Annual Conference 23rd Contract Pharma Conference & Tabletop Exhibition 52nd Organic Process Research and Development Conference ChemOutsourcing 2024 2nd Annual ADC Linker and Conjugation Summit CBA-China 2024 CPHI China 2024 Chemspec Europe 2024 CPHI North America 2024 12th Annual Advances in Chemical Sciences Symposium DCAT Week 2024 51st Organic Process Research & Development Conference 6th Flow Chemistry and Continuous Processing Conference News Room Apeloa Jiayuan successfully completed a U.S. FDA cGMP inspection APELOA proudly introduces our latest API product, Gabapentin APELOA has obtained FDA approval for Amantadine Hydrochloride Tablets (100mg) Grand Opening of the Apeloa Pharma Solutions R&D Center in Billerica, MA Dr. Yong-Li Zhong as Chief Technology Officer, Chemistry 2024 Interim Report Highlights APELOA has obtained FDA approval for our Metoprolol Succinate Extended-Release Tablets Apeloa is among the Top 5 in the China Pharmaceutical CDMO Companies Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024! Hasten Biopharmaceutical Forms Strategic Partnership with Apeloa Pharmaceutical to Enhance Healthcare Innovation Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held

Careers

We value your privacy

To enhance user experience and protect your rights and privacy, please review our Privacy Policy and Legal Statement . By clicking "Accept All", you acknowledge and accept the above terms.

Reject All

Accept All